FMR LLC

Position in BCAX — Bicara Therapeutics Inc.

CIK 315066 BOSTON, MA

Position in BCAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$41,787,477

-$14,546,284 QoQ

Shares Held

2,100,929

-37.2% QoQ

Ownership

3.20%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 99.96725258207204.ToString("F0")% Shared 0.ToString("F0")% None 0.03274741792797377.ToString("F0")%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,682,018,247 across 354 Biotechnology names. BCAX ranks #103 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$41,787,477	2,100,929	-37.2%	Shares	Defined	2026-05-15
2025-12-31	$56,333,761	3,347,223	+24.0%	Shares	Defined	2026-02-17
2025-09-30	$42,607,118	2,698,361	-2.1%	Shares	Defined	2025-11-13
2025-07-10	$27,341,672	2,756,217	+8.6%	Shares	Sole	2025-07-17
2025-06-30	$23,581,772	2,538,404	-29.7%	Shares	Defined	2025-08-14
2025-03-31	$47,058,794	3,611,573	+28.8%	Shares	Defined	2025-05-12
2025-02-24	$36,393,414	2,803,807	+32.4%	Shares	Sole	2025-03-03
2024-12-31	$36,879,671	2,117,088	-6.9%	Shares	Defined	2025-02-13
2024-09-30	$57,913,481	2,273,792	—	Shares	Defined	2024-11-13
No filing history on record for this holder in this stock.